stock market photo

You should be investing for a reason or a goal. For most people, the reason is your retirement. If that is the case, this article may not help you. Your retirement is a long term event where you will have to continue to draw cash for 10, 20 or even 30 years.

This article is for those that are investing for an immediate goal such as

  • Buying a house
  • Buying a car
  • Paying for a vacation
  • College expenses

When you are saving for an event, your thinking about risk needs to transition from long-term to short-term. You need to start asking yourself if the benefits of the short-term gain start to become outweighed by short-term risk.

The market is not friendly, but it is rewarding. At any given time, we are probably only a few weeks from a series of events that will cause the market to correct by 10%. These events are not always foreseeable, and they may not even be rational. However, geopolitical events tied with earning reports of some specific companies could spook major investors and cause a correction. This is life as an investor. If you follow my advice in my book, The Confident Investor, you will eliminate much of your losses for these downturns but you won’t eliminate all of those losses.

When the market suffers a loss, and you have followed my book’s advice, you will suffer a small loss but will be in a position to grow your portfolio dramatically. My book teaches you to take advantage of these opportunities. However, those opportunities require a bit of patience and a bit of time. If you are saving for a specific expense like a new home, you may not have that time. If you are saving for retirement, you do have that time since your retirement will hopefully last for decades. Your house purchase though probably only has a realistic window of a couple months and maybe a couple weeks. Several months is not enough time to increase your profit after a market correction.

When the current short-term outlook potential is higher for a loss than an increase, you need to preserve your capital. You cannot tolerate a loss as much as you can tolerate not earning another 1-2% on your investments. If the market drops 10%, then you won’t have time to make that up before you need the cash. If the market continues to increase, it will only increase 1-2% in the short term.

If you are six months away from making a major purchase such as a house or a car, your likely gain on that capital is probably 6-10% for the half year. If a market correction happens, your loss is likely to be 5-10% depending on your diligence of following the indicators. That gain is approximately equal to the loss. However, the loss may cause you to not afford the purchase. In this case, you need to lock in your cash so that you can afford the expenditure. If your purchase timeframe is longer, it may make sense to continue to ride the market.

As you get closer to your expenditure date, pull your investments into cash. You are no longer in “long term” mode, and you are now in “short term” mode. The pain of a small correction may be very large for you. Don’t be afraid to protect your gains to achieve your goals.

 

Company name Alexion Pharmaceuticals, Inc.
Stock ticker ALXN
Live stock price [stckqut]ALXN[/stckqut]
P/E compared to competitors Fair

MANAGEMENT EXECUTION

Employee productivity Good
Sales growth Good
EPS growth Good
P/E growth Good
EBIT growth Good

ANALYSIS

Confident Investor Rating Good
Target stock price (TWCA growth scenario) $277.78
Target stock price (averages with growth) $306.91
Target stock price (averages with no growth) $139.23
Target stock price (manual assumptions) $277.03

The following company description is from Google Finance: http://www.google.com/finance?q=alxn

Alexion Pharmaceuticals, Inc. (Alexion), is a biopharmaceutical company focused on serving patients with severe and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products. Its marketed product Soliris (eculizumab) is the first and only therapeutic approved for patients with two ultra-rare and severe disorders resulting from chronic uncontrolled activation of the complement component of the immune system: paroxysmal nocturnal hemoglobinuria (PNH), an ultra-rare and life-threatening blood disorder, and atypical hemolytic uremic syndrome (aHUS), an ultra-rare and life-threatening genetic disease. The Company is also evaluating other indications for Soliris in other diseases in which chronic uncontrolled complement activation is the underlying mechanism, and it is progressing with other biotechnology product candidates in ultra-rare and severe disorders, which are in various stages of development.

 

Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in Alexion Pharmaceuticals, Inc.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor. You can review the best companies that I have found (and I probably invest my own money in most of these companies) in my Watch List.

How was this analysis of Alexion Pharmaceuticals, Inc. calculated?

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(access_s2member_level1)]

In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

  • Stock price at the time of the calculation: $179.67
  • Growth: 0.2
  • Current EPS (TTM): $3.26
  • P/E: 55
  • Future EPS Calc: $8.11
  • Future Stock Price Calc: $446.15
  • Target stock price: $277.02

[/s2If]
I hope that this makes you a Confident Investor.

Company name Akamai Technologies, Inc.
Stock ticker AKAM
Live stock price [stckqut]AKAM[/stckqut]
P/E compared to competitors Fair

MANAGEMENT EXECUTION

Employee productivity Fair
Sales growth Good
EPS growth Good
P/E growth Good
EBIT growth Good

ANALYSIS

Confident Investor Rating Good
Target stock price (TWCA growth scenario) $108.57
Target stock price (averages with growth) $103.77
Target stock price (averages with no growth) $47.38
Target stock price (manual assumptions) $97.24

The following company description is from Google Finance: http://www.google.com/finance?q=akam

Akamai Technologies, Inc., is a technology solutions company. The Company provides cloud services for delivering, optimizing and securing online content and business applications. The Company’s solutions enable delivery of conventional content on websites, tools supporting delivery and operation of cloud-based applications, live and on-demand streaming video capabilities. These services assist the customers to interact with people accessing the Internet from devices and locations across the world. The Company’s Solutions include: Media Delivery Solutions, Performance and Security Solutions, and Service and Support Solutions. Media Delivery Solutions, enables enterprises to execute digital media and software distribution strategies. Performance and Security Solutions, designed for core content and application delivery and security technologies. Service and Support Solutions, offers professional services and solutions to customers.

 

Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in Akamai Technologies, Inc.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor. You can review the best companies that I have found (and I probably invest my own money in most of these companies) in my Watch List.

How was this analysis of Akamai Technologies, Inc. calculated?

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(access_s2member_level1)]

In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

  • Stock price at the time of the calculation: $70.4
  • Growth: 0.175
  • Current EPS (TTM): $1.84
  • P/E: 38
  • Future EPS Calc: $4.12
  • Future Stock Price Calc: $156.59
  • Target stock price: $97.23

[/s2If]
I hope that this makes you a Confident Investor.